100 μg
BioServUK now offers recombinant, chimeric antibodies, containing mouse variable domains (VL+VH) with human IgG1 (CH) and kappa (CL) constant domains.
This antibody has been validated by ELISA and is specifically directed against an epitope that is located within the S1-subunit but outside the receptor-binding domain (RBD). The recombinant antibodies are produced under serum‐free conditions in human embryonic kidney, HEK293 cells and purified through one-step purification with Protein-A affinity chromatography.